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Introduction: The clinical benefit of continued supervised maintenance exercise programs 
following pulmonary rehabilitation in COPD remains unclear. This systematic review aimed to 
synthesize the available evidence on the efficacy of supervised maintenance exercise programs 
compared to usual care following pulmonary rehabilitation completion on health care use 
and mortality.
Methods: Electronic databases (MEDLINE, Embase, CINAHL, Cochrane Central Register of 
Controlled Trials, Web of Science, and PEDro) and trial registers (ClinicalTrials.gov and Current 
Controlled Trials) were searched for randomized trials comparing supervised maintenance 
exercise programs with usual care following pulmonary rehabilitation completion. Primary 
outcomes were respiratory-cause hospital admissions, exacerbations requiring treatment with 
antibiotics and/or systemic corticosteroids, and mortality.
Results: Eight trials (790 COPD patients) met the inclusion criteria, six providing data for 
meta-analysis. Continued supervised maintenance exercise compared to usual care following 
pulmonary rehabilitation completion significantly reduced the risk of experiencing at least one 
respiratory-cause hospital admission (risk ratio 0.62, 95% confidence interval [CI] 0.47–0.81, 
P,0.001). Meta-analyses also suggested that supervised maintenance exercise leads to a clini-
cally important reduction in the rate of respiratory-cause hospital admissions (rate ratio 0.72, 
95% CI 0.50–1.05, P=0.09), overall risk of an exacerbation (risk ratio 0.79, 95% CI 0.52–1.19, 
P=0.25), and mortality (risk ratio 0.57, 95% CI 0.17–1.92, P=0.37).
Conclusion: In the first systematic review of the area, current evidence demonstrates that 
continued supervised maintenance exercise compared to usual care following pulmonary 
rehabilitation reduces health care use in COPD. The variance in the quality of the evidence 
included in this review highlights the need for this evidence to be followed up with further 
high-quality randomized trials.
Keywords: pulmonary rehabilitation, health outcomes, supervised maintenance programs, 
hospitalization, exacerbations
Introduction
Pulmonary rehabilitation is defined as “a comprehensive intervention based on a 
thorough patient assessment followed by patient-tailored therapies that include, but 
are not limited to, exercise training, education, and behavior change, designed to 
improve the physical and psychological condition of people with chronic respiratory 
disease and to promote the long-term adherence to health-enhancing behaviors.”1 
Pulmonary rehabilitation has well-established benefits in improving exercise capacity, 
health-related quality life, and psychological well-being in chronic lung conditions such 
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as COPD.1,2 The strength of the evidence for these benefits in 
COPD has led to calls for an end to randomized controlled 
trials comparing pulmonary rehabilitation with usual care.3 
However, the benefits of pulmonary rehabilitation have been 
shown to be short term2 with the condition of most patients 
returning to baseline at 12 months.4 Consequently, there is 
interest in exercise programs that may maintain the initial 
benefits of pulmonary rehabilitation.5,6
Supervised maintenance exercise programs after pul-
monary rehabilitation in COPD appear to be more effective 
in preserving the improvements in exercise capacity up to 
6 months but show no effects with respect to health-related 
quality of life postrehabilitation.5,7 Exacerbations and hospital 
admissions are the key events in the management of COPD, 
but the effects of exercise, particularly supervised mainte-
nance programs following pulmonary rehabilitation, on these 
outcomes have received little attention. A recent systematic 
review has highlighted the role of pulmonary rehabilitation 
in reducing hospitalizations due to COPD exacerbations.8 
This supported a previous systematic review that showed a 
reduction in the risk of hospital readmission when complet-
ing pulmonary rehabilitation following exacerbation,9 albeit 
the quality of this evidence has recently been downgraded 
due to inconsistencies in the estimates of effect.10 There is 
increasing interest in assessing these outcomes in response 
to exercise interventions following pulmonary rehabilitation 
to identify if the duration of benefits from a pulmonary reha-
bilitation program alone can be prolonged or rather enhanced 
during the postrehabilitation period.8 A previous systematic 
review of supervised maintenance exercise programs fol-
lowing pulmonary rehabilitation in COPD had included 
studies that reported health care use; however, data were not 
statistically combined to quantify effect size.5 Despite the 
availability of new evidence in the area since this review, 
there remains no systematic review that has synthesized the 
evidence of the effects of supervised maintenance exercise 
training programs compared to usual care following pulmo-
nary rehabilitation on outcomes related to health care use. 
Therefore, the aim of this systematic review was to collate 
and synthesize all of the available evidence from randomized 
controlled trials in order to estimate the size of the effect 
of supervised maintenance exercise programs following 
pulmonary rehabilitation on health care use.
Methods
The protocol for this study (CRD42016035509) was 
registered in advance on PROSPERO (International Pro-
spective Register of Systematic Reviews; www.crd.york.
ac.uk/PROSPERO/).
selection criteria
Participants
Adults with a confirmed diagnosis of COPD (in line with 
national or international criteria, eg, British Thoracic 
Society, American Thoracic Society/European Respiratory 
Society, and Global Initiative for Chronic Obstructive Lung 
Disease) who had completed a pulmonary rehabilitation 
program.11–13
Intervention
Studies were included if patients were randomized to a 
supervised maintenance exercise training program following 
pulmonary rehabilitation.
Comparison
The comparator was any concurrent control group who had 
completed pulmonary rehabilitation and returned to “usual 
care.”
Outcomes
Primary outcomes were hospital admissions (respiratory 
cause), exacerbations requiring treatment with antibiotics 
and/or systemic corticosteroids, and all-cause mortality.
Secondary outcome measures were hospital admissions 
(all-cause), outpatient visits, length of hospital stay (respira-
tory or all-cause), and general practitioner (GP) visits.
Study design
Studies included in this review had to have adhered to the 
following study designs: parallel-group randomized con-
trolled trials (allocation at individual or cluster level or using 
quasi-random method) or crossover randomized controlled 
trials (data up to point of crossover only).
Search strategy
Searches were conducted to identify any relevant completed 
or ongoing systematic reviews using the following sources: 
Cochrane Database of Systematic Reviews, Database of 
Abstracts of Reviews of Effects, and PROSPERO. Published 
trials were identified through searches on the following 
bibliographic databases: MEDLINE, Embase, CINAHL, 
Cochrane Central Register of Controlled Trials, Web of 
Science, and PEDro. Searches of ongoing trial registers, such 
as ClinicalTrials.gov and Current Controlled Trials, were also 
undertaken. Gray literature was also searched via EThOS 
(British Library) and Conference Proceedings Index (Web 
of Science Core Collection). Searches were conducted from 
database inception to August 2017. No limits were set on 
language or publication status. Search terms were structured 
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around the population (eg, “Lung Diseases, Obstructive”, 
“COPD”), intervention (eg, “Exercise Therapy”, “exercis* 
N3 supervi* OR training OR maintenance OR program*”), 
and study type (eg, “randomised”, “randomized”, “con-
trolled”). An example of a full search strategy for CINAHL is 
presented in Table S1. Database searching was supplemented 
by contact with study authors and research groups, forward 
and backward citation tracking from included studies or 
previous relevant reviews, with further Internet searching 
via Google Scholar until August 2017.
Search results were collated using EndNote (Clarivate 
Analytics, Philadelphia, PA, USA). Duplicate citations were 
removed prior to independent screening of title and abstracts 
according to inclusion criteria by two reviewers. Full-text 
articles were obtained for all studies that were unable to be 
excluded based on title and abstract, before further indepen-
dent screening to decide on final eligibility. Discrepancies in 
study eligibility were resolved through discussion between 
reviewers.
Data extraction and quality appraisal
Data extraction took place using a modified Cochrane Data 
Extraction Template including elements adapted from a 
taxonomy form previously used in randomized controlled 
trials.14 Data were extracted by one reviewer and checked 
for accuracy by a second reviewer. List of characteristics 
extracted from studies is available in the Supplementary 
materials.
Two reviewers independently assessed the risk of bias 
for included studies using the Cochrane Risk of Bias Tool 
with the following domains: random sequence generation, 
allocation concealment, blinding of outcome assessment, 
incomplete outcome data, selective outcome reporting, and 
other bias.15 Each domain was classified as low, unclear, or 
high with the risk of bias for each study classified using the 
following criteria: 1) low risk of bias (all criteria were deemed 
low), 2) medium risk of bias (one criterion graded as high 
or two criteria graded as unclear), and 3) high risk of bias 
(more than one criterion was deemed high or more than two 
criteria graded unclear). Disagreements between reviewers 
were resolved through further discussion.
Data analysis
All analyses were performed using Review Manager Version 
5.3. The primary measures of effect were treated as dichoto-
mous data (defined as the total number of participants in each 
group who had been hospitalized for respiratory cause, treated 
for an exacerbation, or died [all-cause]) and interpreted as risk 
ratios. Rate ratio of hospital admissions (respiratory-cause) 
and exacerbations was also calculated using the incidence rate 
in the intervention groups divided by the incidence rate in the 
control groups. Secondary outcomes of hospital admissions 
(all-cause), GP visits (all-cause), and outpatient visits were 
treated as dichotomous outcomes only and were interpreted as 
risk ratios. Length of hospital admissions (respiratory and all-
cause) were analyzed as a continuous outcome and expressed 
as the between-groups difference in means. All primary and 
secondary outcomes were analyzed using raw data provided 
by authors rather than mean values presented in publications. 
If studies reported the same outcome measures, data were 
combined statistically using a random-effects meta-analysis. 
We contacted study authors to obtain missing numerical 
outcome data, and in cases where studies only reported 
certain outcomes of health care use, we verified that no 
additional data were available. The generic inverse-variance 
random-effects model for rates of hospitalization (respira-
tory) and exacerbation included the (natural) logarithms 
of the rate ratios and the standard error of the rate ratio.15 
Statistical heterogeneity was assessed by the I2 value. Data 
were not pooled if heterogeneity was found to be moderate 
(I2.30%). If heterogeneity was identified, potential sources 
were explored. Prespecified subgroup analyses included the 
setting, frequency, and delivery (training level of supervisor, 
combined with education) of supervised maintenance exer-
cise programs. To test the robustness of findings in primary 
outcome measures, planned prespecified sensitivity analyses 
involved the removal of studies categorized as medium or 
high risk of bias within the Cochrane Risk of Bias Tool.
Results
After the removal of duplicates, searches identified 3,730 
records to be screened, of which 3,688 records were excluded 
based on title and abstract (Figure 1). Full texts were obtained 
for the remaining 42 records. Information on excluded texts 
and reasons for these can be found in Table S2. Ten records 
(eight studies) met the inclusion criteria (Table 1), of which 
six studies had data available for meta-analysis. Two studies 
were excluded from the meta-analysis due to data not being 
available in the appropriate format16 and outcome definitions 
(eg, exacerbation) not meeting review eligibility criteria.17
Characteristics of included studies
The eight included studies were published between 2002 
and 2017 (Table 1). The eight studies, in total, randomized 
790 COPD patients (64% males), with study sample sizes 
ranging between 40 and 164. All stages of COPD severity 
(airflow limitation) were represented across included studies. 
All studies, except Moullec et al,23,24 randomized patients to 
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either a control group (usual care) or a supervised mainte-
nance exercise program following pulmonary rehabilitation. 
Moullec et al23,24 used a quasi-random method, whereby 
patients were consecutively assigned following pulmonary 
rehabilitation discharge. All supervised maintenance exercise 
interventions lasted between 9 and 12 months except for 
Guell et al25 who provided a program for 36 months. Ringbaek 
et al19 and Ries et al16 had 6- and 12-month observation peri-
ods, respectively, following the completion of supervised 
maintenance exercise, data for which were not relevant 
for analysis in this review. Intervention procedures varied 
considerably between studies with one study providing an 
intense program of 3.5 h of supervised maintenance exercise 
a week,23,24 whereas another study provided one supervised 
maintenance session every 3 months.20,21 More details on 
interventions for all of the studies are given in Table 1.
Primary and secondary outcomes of this review were 
determined by either self-reporting of events by patients16,17 
or self-report validated through examination of health 
records.18–25 Health care use was reported as a secondary 
outcome in the majority of studies16–24 with the publication 
of one study not reporting relevant outcomes.25 Contact with 
authors of this study provided unpublished data relevant to 
this review. None of the studies had outcome data for all 
planned meta-analyses.
The risk of bias assessment was hindered by poor study 
reporting. Some studies presented with several unclear risks 
of bias domains, leading to overall high risk of bias. Due to 
high attrition rates, the risk of bias in four of the included 
studies in the meta-analyses was classified as high (Table 2). 
The only study with a low risk of bias was unable to be 
included in meta-analyses due to the lack of availability 
of data.16
Primary outcomes
Hospital admissions (respiratory cause)
Meta-analysis of five trials18,20,22–25 demonstrated a statisti-
cally significant reduction in the risk of experiencing at least 
one respiratory-cause hospital admission with continued 
supervised maintenance exercise following pulmonary 
rehabilitation (risk ratio 0.62, 95% confidence interval (CI) 
0.47–0.81, P,0.001) (Figure 2A). There were no indications 
of heterogeneity in the findings (I2=0%).
Three trials provided data on incidence rates,18,20,25 
whereby the overall estimate of the average effect suggested 
a reduction in the rate of respiratory-cause hospital admis-
sions with supervised maintenance exercise (rate ratio 0.72, 
95% CI 0.50–1.05, P=0.09, I2=0%) (Figure 2B).
Exacerbations requiring treatment with antibiotics 
and/or systemic corticosteroids
Meta-analysis of two trials18,22 suggested a reduction in the 
risk of experiencing at least one exacerbation with supervised 
maintenance exercise (risk ratio 0.79, 95% CI 0.52–1.19, 
????????????????????????????????????????????????????
?????????????????????????????????????
?????????????????????????????????????????????????
??????????????????????
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Figure 1 Flow diagram of study selection.
Note: asome studies excluded for multiple reasons.
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P=0.25, I2=0%) (Figure 3A). Synthesis of the incidence rates 
of exacerbations in these studies suggested a minimal effect 
of supervised maintenance exercise (rate ratio 0.95, 95% CI 
0.67–1.37, P=0.80, I2=0%) (Figure 3B).
Mortality
Meta-analysis of two trials18,20 suggested a reduction in the 
risk of all-cause mortality with supervised maintenance 
exercise, but this was not statistically significant (risk ratio 
0.57, 95% CI 0.17–1.92, P=0.37, I2=0%) (Figure 4). The trial 
by Roman et al22 was omitted from this analysis due to no 
events occurring in either group during the trial.15
Secondary outcomes
Hospital admissions (all-cause)
Meta-analysis of three trials19,20,23 suggested a greater risk of 
experiencing at least one all-cause hospital admission with 
supervised maintenance exercise (risk ratio 1.14, 95% CI 
0.80–1.62, P=0.48, I2=0%) (Figure S1).
Length of stay (respiratory cause and all-cause)
One trial provided data for length of hospital stay due to 
respiratory cause18 (mean difference -1.60, 95% CI -4.73 
to 1.53, P=0.32), and one trial provided data for length of 
hospital stay due to all-cause19 (mean difference -0.20, 
95% CI -2.31 to 1.91, P=0.85) with both favoring a shorter 
length of stay with supervised maintenance exercise.
Outpatient visits
Only one trial provided data for outpatient visits.20 The 
overall estimate of effect suggested a nonsignificant reduc-
tion in the risk of experiencing at least one outpatient visit 
with supervised maintenance exercise (risk ratio 0.78, 
95% CI 0.53–1.14, P=0.20).
gP visits
Meta-analysis of three trials18,20,22 suggested a minimal 
reduction in the number of patients making at least one GP 
visit with supervised maintenance exercise (risk ratio 0.92, 
95% CI 0.75–1.11, P=0.38, I2=0%) (Figure S2).
Sensitivity analyses
As all studies included in the meta-analyses were assessed 
to have a medium or high risk of bias, we were unable to 
perform our prespecified sensitivity analyses. However, we 
deemed that a sensitivity analysis was required on our out-
come of the risk of respiratory-cause hospital admissions due 
to the presence of one study25 that had a substantially longer 
intervention (and follow-up period) (36 months).
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Assessing the number of patients suffering one or more 
exacerbation between groups (ie, risk ratio) will show the direc-
tion of the intervention effect, but it is heavily influenced by the 
duration of the trial.26 Pooled analyses excluding Guell et al25 led 
to the loss of statistical significance and reduction in the overall 
effect of supervised maintenance exercise on the overall risk 
of experiencing at least one respiratory-cause admission (risk 
ratio 0.81, 95% CI 0.43–1.52, P=0.51) (Figure 5). Admission 
data were also retrieved from the study authors for the 1 year 
follow-up of this study, to allow further scrutiny of the effect 
of the duration of follow-up. Pooled analyses including the 
12-month follow-up of Guell et al25 also led to loss of statistical 
significance and reduction in the overall effect of supervised 
maintenance exercise on the overall risk of experiencing at 
least one respiratory-cause hospital admission (risk ratio 0.77, 
95% CI 0.47–1.25, P=0.29) (Figure 6). Due to limited number 
of completed trials, it was not possible to perform meaningful 
synthesis of prespecified subgroups on our primary outcomes.
Discussion
To our knowledge, this is the first systematic review to 
identify eight completed randomized trials that compared 
the efficacy of supervised maintenance exercise following 
pulmonary rehabilitation with usual care on health care use 
in COPD, six of which had relevant data to be synthesized 
using meta-analysis.
Table 2 Risk of bias assessment
Study Random 
sequence 
generation
Allocation 
concealment
Blind 
outcome 
assessment
Incomplete 
outcome 
data
Selective 
reporting 
(reporting bias)
Other 
bias
Overall 
risk
Ries et al (2003)16 low low low low low low low
Brooks et al (2002)17 low low Unclear High low low Medium
Spencer et al (2010)18 low low High low low low Medium
Ringbaek et al (2010)19 Unclear Unclear Unclear low low low High
Wilson et al (2015)20 and 
Burns et al (2016)21
low low low High low low Medium
Roman et al (2013)22 low Unclear Unclear High low low High 
Moullec et al (2008)23 and 
Moullec and Ninot (2010)24
High High Unclear High low low High
Guell et al (2017)25 low low Unclear High High low High
0.01 0.1 1 10 100
Risk ratio IV,
random, 95% CI
ControlExperimental
Favors
(experimental)
Favors
(control)
Heterogeneity: τ2=0.00; χ2=2.69, df=4 (P=0.61); I2=0%
Test for overall effect: Z=3.46 (P=0.0005)
Events
19
3
5
6
33
0
31
132
30
34
26
Total
11
6
49
30
5
6
Events
2
28
136
39
31
22
Total
16
6.6
100
4.4
81.0
7.2
Weight
(%)
0.9
0.75 (0.26–2.20)
0.58 (0.43–0.78)
0.51 (0.14–1.89)
1.30 (0.47–3.63)
0.62 (0.47–0.81)
Risk ratio IV,
random, 95% CI
0.28 (0.01–5.39)
Total (95% CI)
Total events
Study or
subgroup
Guell et al (2017)25
Moullec et al (2008)23
Roman et al (2013)22
Wilson et al (2015)20
Spencer et al (2010)18
0.01 0.1 1 10 100
Rate ratio IV,
random, 95% CI
0.63 (0.27–1.46)
0.65 (0.41–1.03)
1.30 (0.52–3.27)
0.72 (0.50–1.05)
Rate ratio IV,
random, 95% CI
19.2
100
64.5
16.3
Weight
(%)
0.434
0.237
0.471
SE
–0.432
–0.47
0.262
Log (rate ratio)
Favors
(experimental)
Favors
(control)
Heterogeneity: τ2=0.00; χ2=1.87, df=2 (P=0.39); I2=0%
Test for overall effect: Z=1.71 (P=0.09)
Total (95% CI)
Study or
subgroup
Guell et al (2017)25
Wilson et al (2015)20
Spencer et al (2010)18
A
B
Figure 2 Trial-level data, effect estimates, and forest plot of comparison for the overall risk (of experiencing at least one event) (A) and incidence rates (B) of respiratory-
cause hospitalization.
Abbreviations: CI, confidence interval; IV, inverse variance; SE, standard error.
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Summary of main findings
Data synthesis of five trials18,20,22–25 suggests that, on aver-
age, supervised maintenance exercise following pulmonary 
rehabilitation significantly reduces the risk of experienc-
ing at least one respiratory-cause hospital admission by 
38%. The current available evidence is heavily weighted 
by one trial,25 whereby the magnitude of the point estimate 
is sensitive to the inclusion of this trial (due to length of 
follow-up). Synthesized data from three trials18,20,25 suggest 
that, on average, supervised maintenance exercise may also 
have an effect on multiple admissions by reducing the rate 
of respiratory-cause admissions by 28%. While pooling of 
studies for other primary measures in this review (relative 
risk reduction in exacerbations requiring treatment with 
antibiotics and/or systemic corticosteroids and all-cause 
mortality of 21% and 43%, respectively) did not translate to 
statistically significant changes, the point estimates of effect 
do surpass proposed thresholds of clinical significance.26,27 
There is currently no evidence that supervised maintenance 
exercise following pulmonary rehabilitation has an effect 
on the risk of all-cause hospital admission or GP visits. 
Furthermore, there are insufficient data to synthesize the 
effect of supervised maintenance exercise on outpatient visits 
or duration of hospital stay following respiratory-cause and 
all-cause admission.
Strengths and limitations of the review
A strength of this review is that it is the first to conduct 
comprehensive searches and synthesis of published and 
unpublished data on health care use during supervised main-
tenance exercise programs compared to usual care following 
pulmonary rehabilitation. This review followed a preset, 
publicly available protocol detailing specific methodology. 
When the protocol for this review was written however, we 
did not anticipate the inclusion of trials with substantial dif-
ferences in study follow-up. The recent study of Guell et al25 
has received plaudits for conducting such a long follow-up 
period of postpulmonary rehabilitation maintenance.28 
We feel that this deviation from our protocol in performing 
sensitivity analysis was strongly justified on the basis that 
studies with a longer observation period are likely to impact 
the robustness of our findings.
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Figure 3 Trial-level data, effect estimates, and forest plot of comparison for the overall risk (of experiencing at least one event) (A) and incidence rates (B) of exacerbation 
requiring treatment with medication.
Abbreviations: CI, confidence interval; IV, inverse variance; SE, standard error.
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Figure 4 Trial-level data, effect estimates, and forest plot of comparison for the risk of mortality.
Abbreviations: CI, confidence interval; IV, inverse variance.
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Extensive efforts were made to contact all trial authors to 
obtain additional data when outcomes did not appear in the 
available reports. The retrieval of additional data (beyond the 
published literature) reflects a key strength of our review. We, 
however, recognize that two studies16,17 that met review eligi-
bility criteria were not included in our meta-analyses; hence, 
this must be noted as a limitation. We identified inconsistencies 
in how our review outcomes were reported. The majority of 
the studies were limited by expressing hospitalizations/exac-
erbations as mean number of events per study group only and 
simply interpreted as a difference in means. However, a small 
minority of patients who experience multiple events can heav-
ily influence this measure of effect, and the interpretation of 
such estimates is not as informative as when discrete (count) 
data are analyzed as ratios. From a statistical point of view, a 
strength of our review is that our measures of effect make full 
use of the data that have been collected in the included studies. 
Clinically, we allow health care practitioners and other relevant 
stakeholders to be able to interpret the effect of supervised 
maintenance exercise on the risk of whether a patient experi-
ences an exacerbation and the efficacy of the intervention in 
reducing multiple events in the same patient.
The proposed minimal clinically important difference 
in COPD exacerbation frequency is 20%.26,27 As the entire 
range of the confidence interval for the effect of supervised 
maintenance exercise on hospitalization rates (ie, severe 
exacerbation) or risk of an exacerbation treated with anti-
biotics and/or systemic corticosteroids does not exceed the 
threshold of clinical usefulness, we cannot exclude the pos-
sibility that the reduction is of a magnitude not considered 
clinically worthwhile. Hence, the available evidence can be 
considered consistent with either an increase or a decrease 
in hospitalization rates (ie, severe exacerbation) or risk of 
an exacerbation as a result of the intervention.
The proportion of missing outcome data compared to 
observed outcome data in some of the trials20–25 is enough to 
induce a clinically relevant bias in the observed intervention 
effects. There is no consensus on how to handle partici-
pants in a meta-analysis for whom data are not available.15 
We opted for an available case analysis as opposed to inten-
tion to treat analysis using imputation. Although our findings 
do provide an analysis of efficacy, the lack of intention to 
treat approach precludes an effectiveness analysis of the 
supervised maintenance exercise.29
Effects estimated from published studies only may be 
inflated due to bias toward the nonpublication of studies with 
nonsignificant effects. The fact that all of the included pub-
lished studies did not report significant effects of supervised 
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???????????????τ ????????χ ???????????????????????? ????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????????
???????????????? ?????? ????? ???????
????????????????
????????????????????????????????????????????????????????????????
???????????????????????????? ????????????????????????????
??
??
??
??????
????
??
??
??
?????
??
??
??
??????
???
???????????????
?????????
???
????
????
?????
Figure 5 Sensitivity analyses on trial-level data, effect estimates, and forest plot of comparison for the risk of hospital admission for a respiratory cause excluding Guell et al.25
Abbreviations: CI, confidence interval; IV, inverse variance.
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Figure 6 Sensitivity analyses on trial-level data, effect estimates, and forest plot of comparison for the risk of hospital admission for a respiratory cause including 0–12 months 
follow-up of Guell et al.25
Abbreviations: CI, confidence interval; IV, inverse variance.
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maintenance exercise on health care use mitigates concerns 
about publication bias. All of the trials included in the meta-
analyses were classified as having an overall medium or high 
risk of bias. Therefore, the quality of the overall evidence 
presented in this review is low. There were many individual 
domains where the risk of bias was unclear, primarily due 
to incomplete reporting. It is important to consider that this 
may not be poor reporting per se, and rather limitations in 
study design.30 Also, as commonly found in COPD trials, 
especially those .6 months in duration, many studies were 
classified as having high attrition bias.31
Comparison with other reviews
No previous systematic review has synthesized data from ran-
domized controlled trials assessing the effects of supervised 
maintenance exercise following pulmonary rehabilitation 
on health care use. There were three previous systematic 
reviews in COPD that had synthesized the available evidence 
on supervised maintenance programs following pulmonary 
rehabilitation, but meta-analyses were limited to exercise 
capacity and quality of life outcomes.5,7,32 Similarities, with 
regard to the benefits of exercise in our review, can be seen 
with Moore et al8 where data from randomized controlled 
trials on health care use following pulmonary rehabilitation 
alone were synthesized. However, this review did not focus 
on interventions aiming to maintain exercise regimens fol-
lowing pulmonary rehabilitation but instead evaluated the 
short- and long-term benefits of initial pulmonary rehabilita-
tion programs on exacerbations compared to no treatment. 
It was concluded that the delivery of pulmonary rehabilita-
tion to stable COPD patients or patients following acute 
exacerbations results in reduced rates of hospitalizations 
compared to usual care. Our findings suggest that continu-
ing maintenance exercise in a supervised manner following 
pulmonary rehabilitation may further enhance the benefit on 
certain health care use outcomes.
Implications for clinical practice
Based on the evidence presented in this review, it would 
currently be unwise to make specific recommendations on 
clinical care within this area. Due to the low precision (wide 
confidence intervals) in our effect estimates, only one of our 
meta-analyses translated to a statistically significant differ-
ence in health care use as a result of supervised maintenance 
exercise. However, early indications are promising, whereby 
the current point estimates of effect in some of the outcomes 
(eg, exacerbation rate) would be large enough to be classified 
as clinically significant. These clinically significant findings 
could have large implications for future postrehabilitation care. 
While there are proposals that “one size does not fit all” 
with pulmonary rehabilitation maintenance,28 supervised 
maintenance exercise will likely play an important part in 
future practice recommendations. Arguably, the funding and 
reimbursement of supervised maintenance programs may 
largely depend on evaluations of cost-effectiveness. In theory, 
offering continued supervised maintenance exercise pro-
grams following pulmonary rehabilitation may not be cost-
effective in the short term due to the initial outlay of setting 
up a program;21,33 however, the potential reductions in health 
care use in the medium to long term seen within this review 
may be large enough to produce a favorable cost–benefit ratio 
to health care budgets. This review highlights the importance 
of this active area of research and upon completion of further 
studies, its influence on future clinical practice.
Implications for future research
The findings of our meta-analyses must be interpreted in 
relation to quality and quantity of available evidence. The 
low precision of the individual study estimates (as a result 
of small sample sizes and hence low number of events) 
widens the confidence intervals for the point estimates of 
effect, highlighting the important impact that further research 
could have.
Further randomized trials addressing the current uncer-
tainty about the effects of supervised maintenance exercise 
versus usual care on outcomes such as mortality and risk of 
exacerbation would need to be large (in sample size and/or 
a duration of follow-up $12 months). None of the included 
studies reported an a priori sample size calculation to deter-
mine the effect of supervised maintenance exercise on out-
comes related to health care use.18,20,22,25 Future studies should 
include an appropriately powered sample size calculation 
based on proposed minimal clinically important differences. 
These studies should also adopt proper statistical analysis of 
outcomes (particularly exacerbations). Typical distribution 
of COPD exacerbations data and recommended statistical 
approaches have been discussed elsewhere.34,35 To facilitate 
critical appraisal and interpretation, future randomized trials 
would also benefit from adhering to Consolidated Standards 
of Reporting Trials (CONSORT) guidelines.
Our findings have general applicability to all stable COPD 
patients referred to pulmonary rehabilitation. As none of the 
included trials stratified randomization by COPD severity, 
it is unclear whether our findings are equally applicable to 
all stages of COPD severity or exacerbation status. Further 
research is required to ascertain the effects of supervised 
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maintenance exercise programs following early rehabilitation 
programs where patients are inherently considered to have a 
greater baseline risk of health care use. Similarly, our review 
was limited to patients with a diagnosis of COPD; efficacy 
of exercise maintenance options for other chronic respiratory 
conditions requires attention.
During our searches, we identified two protocols of 
randomized trials (based in the USA and Canada) that 
meet our eligibility criteria (Table S3).36,37 Compared to 
usual care following pulmonary rehabilitation, one study36 
is randomizing patients to Tai Chi classes, or a walk-
ing group for a 6-month period, while another study37 is 
randomizing patients to a 12-month community exercise 
program. An update on the synthesis of the available evi-
dence would be encouraged upon completion of the trials. 
For the design and delivery of new trials, research teams 
should note recent recommendations from the Australian 
and New Zealand Pulmonary Rehabilitation Guidelines6 
that maintenance programs of monthly or three monthly 
supervised exercises (or less frequently) are insufficient to 
maintain exercise capacity or quality of life. It is reasonable 
to suggest that this frequency of supervised maintenance 
exercise compared with usual care is also unlikely to benefit 
outcomes related to health care use. However, we recog-
nize that there is growing interest in different approaches 
to maintain the benefits of pulmonary rehabilitation, for 
example, telerehabilitation,38 telecoaching,39 and pedometer 
feedback.40
Conclusion
This systematic review and meta-analysis suggests that 
supervised maintenance exercise programs compared to usual 
care following pulmonary rehabilitation may be beneficial in 
reducing health care use. However, the quality of the avail-
able evidence was variable. This outlines the requirement for 
methodologically sound and large studies to provide more 
precise estimates for the effects of postpulmonary rehabilita-
tion maintenance.
Acknowledgments
We acknowledge the cooperation of authors (Rosa Guell, 
Pilar Cejudo Ramos, Lissa Spencer, Miguel Roman, 
Magdalena Esteva, Thomas Ringbaek, Ed Wilson, and Greg 
Moullec) of the included studies in this review for provid-
ing data in a format appropriate for analyses. We also thank 
Marilyn Moy, Laura Desveaux, and Dina Brooks for pro-
viding updates on their current ongoing trials related to this 
review. This review was conducted during Alex R Jenkins’ 
PhD studentship, which was part of the Doctoral Training 
Alliance Applied Biosciences for Health Programme.
Disclosure
The authors report no conflicts of interest in this work.
References
 1. Spruit M, Singh S, Garvey C, et al. An official American Thoracic 
Society/European Respiratory Society statement: key concepts and 
advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 
2013;188(8):13–64.
 2. McCarthy B, Casey D, Devane D, Murphy K, Murphy E, Lacasse Y. 
Pulmonary rehabilitation for chronic obstructive pulmonary disease. 
Cochrane Database Syst Rev. 2015;(2):CD003793.
 3. Lacasse Y, Cates CJ, McCarthy B, et al. This Cochrane Review is closed: 
deciding what constitutes enough research and where next for pulmo-
nary rehabilitation in COPD. Cochrane Database Syst Rev. 2015;(11): 
ED000107.
 4. Mador MJ, Patel AN, Nadler J. Effects of pulmonary rehabilitation on 
activity levels in patients with chronic obstructive pulmonary disease. 
J Cardiopulm Rehabil. 2011;31(1):52–59.
 5. Beauchamp MK, Evans R, Janaudis-Ferreira T, Goldstein RS, Brooks D. 
Systematic review of supervised exercise programs after pulmo-
nary rehabilitation in individuals with COPD. Chest. 2013;144(4): 
1124–1133.
 6. Alison JA, McKeough ZJ, Johnston K, et al. Australian and New Zealand 
pulmonary rehabilitation guidelines. Respirology. 2017;22:800–819.
 7. Busby AK, Reese RL, Simon SR. Pulmonary rehabilitation maintenance 
interventions: a systematic review. Am J Health Behav. 2014;38(3): 
321–330.
 8. Moore E, Palmer T, Newson R, Majeed A, Quint JK, Soljak MA. 
Pulmonary rehabilitation as a mechanism to reduce hospitalizations for 
acute exacerbations of COPD: a systematic review and meta-analysis. 
Chest. 2016;150(4):837–859.
 9. Puhan MA, Gimeno-Santos E, Scharplatz M, et al. Pulmonary rehabilita-
tion following exacerbations of chronic obstructive pulmonary disease. 
Cochrane Database Syst Rev. 2011;(10):CD005305.
 10. Puhan MA, Gimeno-Santos E, Cates CJ, et al. Pulmonary rehabilita-
tion following exacerbations of chronic obstructive pulmonary disease. 
Cochrane Database Syst Rev. 2016;(12):CD005305.
 11. British Thoracic Society. Chronic Obstructive Pulmonary Disease 
in Over 16s: Diagnosis and Management. London: British Thoracic 
Society; 2011.
 12. American College of Physicians, American College of Chest Physi-
cians, American Thoracic Society, et al. Diagnosis and management 
of stable chronic obstructive pulmonary disease: a clinical practice 
guideline update from the American College of Physicians, American 
College of Chest Physicians, American Thoracic Society, and European 
Respiratory Society. Ann Intern Med. 2011;155(3):179–191.
 13. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy 
for the Diagnosis, Management, and Prevention of COPD – 2016. Avail-
able from: http://goldcopd.org/global-strategy-diagnosis-management-
prevention-copd-2016/. Accessed December 12, 2017.
 14. Lamb SE, Becker C, Gillespie LD, et al. Reporting of complex inter-
ventions in clinical trials: development of a taxonomy to classify and 
describe fall-prevention interventions. Trials. 2011;12:125.
 15. Higgins JPT, Green S [webpage on the Internet], editors. Cochrane 
Handbook for Systematic Reviews of Interventions Version 5.0.2. 
The Cochrane Collaboration; 2009. [updated September 2009]. 
Available from: http://handbook.cochrane.org/v5.0.2/. Accessed 
April 18, 2017.
 16. Ries AL, Kaplan RM, Myers R, et al. Maintenance after pulmonary 
rehabilitation in chronic lung disease. Am J Respir Crit Care Med. 2003; 
167(6):880–888.
 
In
te
rn
at
io
na
l J
ou
rn
al
 o
f C
hr
on
ic 
O
bs
tru
ct
ive
 P
ul
m
on
ar
y 
Di
se
as
e 
do
wn
lo
ad
ed
 fr
om
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
21
2.
21
9.
22
0.
10
7 
on
 1
3-
Ja
n-
20
18
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
International Journal of COPD 2018:13 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
269
Efficacy of supervised exercise following pulmonary rehabilitation
 17. Brooks D, Krip B, Mangovski-Alzamora S, Goldstein RS. The effect 
of postrehabilitation programmes among individuals with chronic 
obstructive pulmonary disease. Eur Respir J. 2002;20:20–29.
 18. Spencer L, Alison JA, McKeough ZJ. Maintaining benefits following 
pulmonary rehabilitation: a randomised controlled trial. Eur Respir J. 
2010;35(3):571–577.
 19. Ringbaek T, Brondum E, Martinez G, et al. Long-term effects of 
1-year maintenance training on physical functioning and health 
status in patients with COPD. J Cardiopulm Rehabil. 2010;30(1): 
47–52.
 20. Wilson AM, Browne P, Olive S, et al. The effects of maintenance 
schedules following pulmonary rehabilitation in patients with chronic 
obstructive pulmonary disease: a randomised controlled trial. BMJ 
Open. 2015;5(3):e005921.
 21. Burns DK, Wilson ECF, Browne P, et al. The cost effectiveness of 
maintenance schedules following pulmonary rehabilitation in patients 
with chronic obstructive pulmonary disease: an economic evaluation 
alongside a randomised controlled trial. Appl Health Econ Health 
Policy. 2016;14(1):105–115.
 22. Roman M, Larraz C, Gomez A, et al. Efficacy of pulmonary rehabilita-
tion in patients with moderate chronic obstructive pulmonary disease: 
a randomized controlled trial. BMC Fam Pract. 2013;14:21.
 23. Moullec G, Ninot G, Varray A, Desplan J, Hayot M, Prefaut C. An 
innovative maintenance follow-up program after a first inpatient pul-
monary rehabilitation. Respir Med. 2008;102(4):556–566.
 24. Moullec G, Ninot G. An integrated programme after pulmonary reha-
bilitation in patients with chronic obstructive pulmonary disease: effect 
on emotional and functional dimensions of quality of life. Clin Rehabil. 
2010;24(2):122–136.
 25. Guell MR, Cejudo P, Ortega F, et al. Benefits of long-term pulmonary 
rehabilitation maintenance program in severe COPD patients: 3 year 
follow-up. Am J Respir Crit Care Med. 2017;195(5):622–629.
 26. Wedzicha JA, Miravitlles M, Hurst JR, et al. Management of COPD 
exacerbations: a European Respiratory Society/American Thoracic 
Society guideline. Eur Respir J. 2017;49(3):1600791.
 27. Jones PW, Beeh KM, Chapman KR, et al. Minimally clinically impor-
tant differences in pharmacological trials. Am J Respir Crit Care Med. 
2014;189(3):250–255.
 28. Rochester C, Spruit M. Maintaining the benefits of pulmonary reha-
bilitation. The Holy Grail. Am J Respir Crit Care Med. 2017;195(5): 
548–551.
 29. Aaron SD, Fergusson D, Marks GB, et al. Counting, analysing and 
reporting exacerbations of COPD in randomised controlled trials. 
Thorax. 2008;63(8):122–128.
 30. Kjaergard LL, Villumsen J, Gluud C. Reported methodologic quality 
and discrepancies between large and small randomized trials in meta-
analyses. Ann Intern Med. 2001;135(11):982–989.
 31. Welsh EJ, Cates CJ, Poole P. Combination inhaled steroid and long-
acting beta2-agonist versus tiotropium for chronic obstructive pulmo-
nary disease. Cochrane Database Syst Rev. 2013;(5):CD007891.
 32. Soysa S, McKeough Z, Spencer L, et al. Effects of maintenance pro-
grams on exercise capacity and quality of life in chronic obstructive 
pulmonary disease. Phys Ther Rev. 2012;17:335–345.
 33. Griffiths TL, Phillips CJ, Davies S, Burr ML, Campbell IA. Cost effec-
tiveness of an outpatient multidisciplinary pulmonary rehabilitation 
programme. Thorax. 2001;56(10):779–784.
 34. Keene ON, Jones MR, Lane PW, Anderson J. Analysis of exacerbation 
rates in asthma and chronic obstructive pulmonary disease: example 
from the TRISTAN study. Pharm Stat. 2007;6(2):89–97.
 35. Keene ON, Calverley PM, Jones PW, Vestbo J, Anderson JA. Statistical 
analysis of exacerbation rates in COPD: TRISTAN and ISOLDE 
revisited. Eur Respir J. 2008;32(1):17–24.
 36. Moy ML, Wayne PM, Litrownik D, et al. Long-term exercise after 
pulmonary rehabilitation (LEAP): design and rationale of a randomized 
controlled trial of Tai Chi. Contemp Clin Trials. 2015;45:458–467.
 37. Desveaux L, Beauchamp MK, Lee A, Ivers N, Goldstein R, Brooks D. 
Effects of a community-based, post-rehabilitation exercise program 
in COPD: protocol for a randomized controlled trial with embedded 
process evaluation. JMIR Res Protoc. 2016;5(2):e63.
 38. Vasilopoulou M, Papaioannou AI, Kaltsakas G, et al. Home-based 
maintenance tele-rehabilitation reduces the risk for AECOPD, hos-
pitalizations and emergency department visits. Eur Respir J. 2017; 
49(5):1602129.
 39. Nguyen HQ, Gill DP, Wolpin S, Steele BG, Benditt JO. Pilot study of 
a cell phone-based exercise persistence intervention post-rehabilitation 
for COPD. Int J Chron Obstruct Pulmon Dis. 2009;4:301–313.
 40. Cruz J, Brooks D, Marques A. Walk2Bactive: a randomised controlled 
trial of a physical activity-focused behavioural intervention beyond 
pulmonary rehabilitation in chronic obstructive pulmonary disease. 
Chron Respir Dis. 2016;13(1):57–66.
 
In
te
rn
at
io
na
l J
ou
rn
al
 o
f C
hr
on
ic 
O
bs
tru
ct
ive
 P
ul
m
on
ar
y 
Di
se
as
e 
do
wn
lo
ad
ed
 fr
om
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
21
2.
21
9.
22
0.
10
7 
on
 1
3-
Ja
n-
20
18
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
International Journal of COPD 2018:13submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
270
Jenkins et al
Supplementary materials
Methods
Data extraction
The following study characteristics were extracted: methods of 
the study (date/title of the study, aim of study, study design, unit 
of allocation, duration of study, duration of intervention, 
primary outcome, secondary outcomes, and funding source), 
participants (population description, demographics, inclusion 
criteria, exclusion criteria, method of recruitment of partici-
pants, total number randomized, clusters, baseline imbalances, 
Table S1 Example search strategy of a bibliographic database (CINAHL)
Number Search term Field
1 Lung diseases, obstructive MH (explode)
2 Lung diseases, interstitial MH (explode)
3 Pulmonary fibrosis MH (explode)
4 COPD TX
5 Chronic obstructive pulmonary disease TX
6 COaD TX
7 COBD TX
8 Emphysem* TX
9 Chronic bronchitis TX
10 Cystic fibrosis TX
11 Pneumoconiosis TX
12 sarcoidosis TX
13 Asthma TX
14 Bronchiectasis TX
15 alveolitis TX
16 Histiocytosis TX
17 granulomatosis TX
18 Bagassosis TX
19 Asbestosis OR byssinosis OR siderosis OR silicosis OR berylliosis OR anthracosilicosis TX
20 scleroderma TX
21 1 Or 2 Or 3 Or 4 Or 5 Or 6 Or 7 Or 8 Or 9 Or 10 Or 11 Or 12 Or 13 Or 14 
Or 15 Or 16 Or 17 Or 18 Or 19 Or 20
22 Exercise therapy MH (explode)
23 Activities of daily living MH (explode)
24 Rehabilitation research Mh 
25 Physical and rehabilitation medicine MH (explode)
26 Physical fitness Mh
27 Exercise movement techniques MH (explode)
28 Telerehabilitation Mh
29 Rehabilitation N2 pulmonary OR respiratory OR physical OR early TI, AB
30 Exercis* N3 supervi* OR training OR maintenance OR program* TI, AB
31 Physical activit* TI, AB
32 Maintenance N2 intervention OR group OR exercise OR program* OR training TI, AB
33 22 Or 23 Or 24 Or 25 Or 26 Or 27 Or 28 Or 29 Or 30 Or 31 Or 32
34 randomised TI, AB
35 Randomized TI, AB
36 Randomly TI, AB
37 Trial TI, AB
38 Controlled TI, AB
39 34 Or 35 Or 36 Or 37 Or 38
40 21 anD 33 anD 39 
Notes: Searches encompassed other chronic lung conditions as part of a wider review. *Truncation operator.
withdrawal and exclusions, and subgroups reported), 
intervention and where relevant comparator (group name, 
number randomized to group-sample size, description, venue 
numbers/locations, duration and frequency of maintenance 
exercise training period, delivery, providers, co-interventions, 
compliance/adherence, and defined parameters of usual care), 
and outcomes (outcome name, outcome type, outcome defini-
tion, person measuring/reporting, unit of measurement, scales 
[upper and lower limits], outcome tool validation, imputation 
of missing data, assumed risk estimate, and level of power).
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Table S2 Characteristics of excluded studies
Study Reason(s) for exclusion
Andrews et al (2015)1 Not a randomized trial
Bernocchi et al (2016)2 Intervention not relevant (unsupervised)
Berry et al (2003)3 Outcomes not applicable
Bertolini et al (2016)4 Not randomized; outcomes not applicable; intervention not relevant (unsupervised)
Brooks et al (2002)5 Outcomes not applicable
Browne et al (2013)6 Conference abstract – full text included
Carrieri-Kohlman et al (2005)7 Intervention not relevant (did not include pulmonary rehabilitation)
Cejudo et al (2014)8 Conference abstract – full text included; outcomes not applicable 
Cejudo et al (2014)9 Conference abstract – full text included; outcomes not applicable
Cruz et al (2016)10 Intervention not relevant (behavioral feedback intervention-unsupervised)
Desveaux et al (2016)11 Ongoing trial – data not available
du Moulin et al (2009)12 Intervention not relevant (unsupervised); outcomes not applicable
Eisner and van Straten (2003)13,a Conference title only
Elliott et al (2004)14 Outcomes not applicable
Fu et al (2016)15 Intervention not relevant (no exercise intervention post-pulmonary rehabilitation)
Gomez et al (2006)16 Conference abstract – full text included
Guell et al (2000)17 Intervention not relevant (control group did not receive pulmonary rehabilitation)
Heppner et al (2006)18 Not a randomized trial
Hill and McDonald (2004)19 Outcomes not applicable
Kotrach et al (2016)20 Intervention not relevant (unsupervised)
Linneberg et al (2012)21 Outcomes not applicable
Martinez et al (2008)22 Conference abstract – full text included
Moy et al (2015)23 Ongoing trial – data not available
Perumal et al (2010)24 Not a randomized trial
Pleguezuelos et al (2013)25 Intervention not relevant (unsupervised); outcomes not applicable
Ries et al (2008)26 Intervention not relevant (unsupervised and control group received additional care); outcomes not applicable
Ringbaek et al (2009)27 Conference abstract – full text included
Rodriguez-Trigo et al (2011)28 Conference abstract – full text included
Scalvini et al (2016)29 Intervention not relevant (unsupervised)
Spencer et al (2007)30 Conference abstract – full text included
Spencer et al (2009)31 Conference abstract – full text included
Swerts et al (1990)32 Outcomes not applicable
van Wetering et al (2010)33 Intervention not relevant (control group did not receive pulmonary rehabilitation); outcomes not applicable
Vasilopoulou et al (2017)34 Intervention not relevant (control group did not receive pulmonary rehabilitation)
Notes: Abstract and full text were nonretrievable. aStudy excluded due to presentation as a conference title only in search results.
0.01 0.1 1 10 100
Risk ratio IV,
random, 95% CI
1.09 (0.30–3.94)
1.14 (0.75–1.72)
1.16 (0.51–2.64)
1.14 (0.80–1.62)
Risk ratio IV,
random, 95% CI
100
73.8
7.6
18.6
Weight
(%)
Control
32
4
19
9
Events
95
39
16
41
Total
3
29
8
40
Events
96
30
11
55
Total
Experimental
Favors
(experimental)
Favors
(control)
Heterogeneity: τ2=0.00; χ2=0.01, df=2 (P=1.00); I2=0%
Test for overall effect: Z=0.71 (P=0.48)
Study or
subgroup
Moullec et al (2008)23
Ringbaek et al (2010)19
Wilson et al (2015)20
Total (95% CI)
Total events
Figure S1 Trial-level data, effect estimates, and forest plot of comparison for the risk of all-cause hospital admission.
Abbreviations: CI, confidence interval; IV, inverse variance.
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Table S3 Ongoing studies
Study name or title Study period 
(start and end 
dates) (country)
Study design Participants Intervention and comparison Relevant outcomes
leaP: design and 
rationale of a 
randomized controlled 
trial of Tai Chi23
august 2012 to 
September 2017 
(USA)
Randomized 
controlled trial 
(2:2:1 ratio)
90 COPD patients 
who have just 
been discharged 
from pulmonary 
rehabilitation
1. Tai Chi (1 h, twice a week for 
3 months, then once a week for 
3 months. A total of 36 classes)
2. Usual care (general 
recommendations for exercise)
3. Walking group (same frequency 
and duration as Tai Chi)
hospital admissions 
(respiratory) 
and acute 
exacerbations (use of 
corticosteroids and/or 
antibiotics verified by 
medical records) 
Effects of a community-
based, postrehabilitation 
exercise program in 
COPD: protocol for a 
randomized controlled 
trial with embedded 
process evaluation11
November 2012 
to august 2018 
(Canada)
Randomized 
controlled trial
100 COPD patients 
who have completed 
pulmonary 
rehabilitation within 
the last 2 weeks
1. Usual care (standard home 
exercise instructions 
postpulmonary rehabilitation)
2. Community-based exercise 
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Figure S2 Trial-level data, effect estimates, and forest plot of comparison for the risk of GP visits.
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